Director Laurie A. Leshin will not stand for reelection at Wiley's 2023 annual meeting

JOHN WILEY & SONS, INC.

Dr. Laurie A. Leshin notified the Board on Aug. 8, 2023, that she will not stand for reelection at the Sept. 28, 2023 annual meeting.
Her departure is due to increased demands at her current position and not due to any disagreement with the company.
Leshin's term as director and Executive Committee member will expire at the annual meeting; the Board size remains at eleven with one vacancy.
The company thanked her for her contributions and perspective as a leading scientist and educator.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Laurie A. Leshin

Director

WLY · JOHN WILEY & SONS, INC.

Effective: 2023-09-28
Filed: August 11, 2023, 7:59 PM ET

On August 8, 2023, Dr. Laurie A. Leshin notified the Board of Directors (the “Board”) of John Wiley & Sons, Inc., (the “Company”) of her intent to not stand for reelection at the Company’s 2023 Annual Meeting of Shareholders (the “Annual Meeting”), to be held on September 28, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Laurie A. Leshin departed as Director at JOHN WILEY & SONS, INC..

Action: not stand for reelection
Role: Director

Exact text from the filing

On August 8, 2023, Dr. Laurie A. Leshin notified the Board of Directors (the “Board”) of John Wiley & Sons, Inc., (the “Company”) of her intent to not stand for reelection at the Company’s 2023 Annual Meeting of Shareholders (the “Annual Meeting”), to be held on September 28, 2023.

View on SEC.gov

JOHN WILEY & SONS, INC. filing history →

Source: SEC EDGAR

accession 0000107140-23-000154

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.